European Companies Search Engine

EU funding (€200,000): 732386 - Treater - Clinical Study in Parkinson's Disease with TWO Unique Goals: 1) Proof-of-Concept of Cdnf Protein for Disease Modification; 2) Validation of Clinically Tested … Fts1 Jan 2017 Financial Transparency System

Overview

Text

Project

Subject of Grant or Contract 732386 - TREATER - CLINICAL STUDY IN PARKINSON'S DISEASE WITH TWO UNIQUE GOALS: 1) PROOF-OF-CONCEPT OF CDNF PROTEIN FOR DISEASE MODIFICATION; 2) VALIDATION OF CLINICALLY TESTED DEVICE FOR INTRACEREBRAL DRUG DELIVERY
Responsible Department RTD - Directorate-General for Research and Innovation
Programme Name 1.1.31 - Horizon 2020
Type of Contract* Action Grant
Reference of the Legal Commitment (LC) JAG.84213
Management Type Direct management
Geographical Zone -
Budget BGUE
Action Location -
Commitment Total Amount (EUR) (A+B) 200,000.00
Project end Date 31/12/2020
Commitment Contracted Amount (EUR) (A) 200,000.00
Budget Line Name Appropriations accruing from contributions from (non-European Economic Area) third parties to research and technological development (2014 to 2020)
Funding Type Grant
Additional/Reduced Amount (EUR) (B) 0.00
Year 2016
Reference (Budget) JAG.84213.1
Commitment Consumed Amount (EUR) 200,000.00
Budget Line Number 08 02 50 01
Project Start Date 01/01/2017
Expense Type Operational

Beneficiaries

  1. Coordinator No
    Address AVENUE BESME 93
    Beneficiary’s Contracted Amount (EUR) 4,835.73
    Beneficiary’s Estimated Contracted Amount (EUR) 4,835.73
    Postal Code 1190
    Beneficiary Country Belgium
    Beneficiary’s Estimated Consumed Amount (EUR) 4,835.73
    VAT Number of Beneficiary BECrossroads Bank for Enterprises (KBO) 0465.299.201
    Beneficiary Group Code LE05
    Not-for-Profit Organisation (Nfpo) Yes
    Beneficiary Type Private Companies
    Name of Beneficiary ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON*EUROPEAN PARKINSON'S DISEASE ASSOCIATION
    NUTS2 Region de Bruxelles-Capitale / Brussels Hoofdstedelijk Gewest
    City BRUXELLES
    Non-Governmental Organisation (NGO) No
  2. Coordinator No
    Address OTTILIAVEJ 7-9
    Beneficiary’s Contracted Amount (EUR) 1,632.84
    Beneficiary’s Estimated Contracted Amount (EUR) 1,632.84
    Postal Code 2500
    Beneficiary Country Denmark
    Beneficiary’s Estimated Consumed Amount (EUR) 1,632.84
    VAT Number of Beneficiary DK56759913
    Beneficiary Group Code LE05
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Private Companies
    Name of Beneficiary ?? ???????? ???
    NUTS2 Hovedstaden
    City VALBY
    Non-Governmental Organisation (NGO) No
  3. Coordinator No
    Address STENBACKINKATU 9
    Beneficiary’s Contracted Amount (EUR) 24,722.95
    Beneficiary’s Estimated Contracted Amount (EUR) 24,722.95
    Postal Code 00029
    Beneficiary Country Finland
    Beneficiary’s Estimated Consumed Amount (EUR) 24,722.95
    VAT Number of Beneficiary FI15675350
    Beneficiary Group Code LE04
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Public Bodies
    Name of Beneficiary ????????? ?? ????????? ????????????????? ???????????????
    NUTS2 -
    City HELSINKI
    Non-Governmental Organisation (NGO) No
  4. Coordinator Yes
    Address FABIANINKATU 33
    Beneficiary’s Contracted Amount (EUR) 19,996.07
    Beneficiary’s Estimated Contracted Amount (EUR) 19,996.07
    Postal Code 14
    Beneficiary Country Finland
    Beneficiary’s Estimated Consumed Amount (EUR) 19,996.07
    VAT Number of Beneficiary FICZ 03134717
    Beneficiary Group Code LE04
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Public Bodies
    Name of Beneficiary HELSINGIN YLIOPISTO*UNIVERSITY OF HELSINKI
    NUTS2 -
    City HELSINGIN YLIOPISTO
    Non-Governmental Organisation (NGO) No
  5. Coordinator No
    Address VIIKINKAARI 4
    Beneficiary’s Contracted Amount (EUR) 30,144.83
    Beneficiary’s Estimated Contracted Amount (EUR) 30,144.83
    Postal Code 00790
    Beneficiary Country Finland
    Beneficiary’s Estimated Consumed Amount (EUR) 30,144.83
    VAT Number of Beneficiary FICZ 21986657
    Beneficiary Group Code LE05
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Private Companies
    Name of Beneficiary HERANTIS PHARMA OYJ
    NUTS2 Helsinki-Uusimaa
    City HELSINKI
    Non-Governmental Organisation (NGO) No
  6. Coordinator No
    Address NOBELS VAG 5
    Beneficiary’s Contracted Amount (EUR) 17,605.42
    Beneficiary’s Estimated Contracted Amount (EUR) 17,605.42
    Postal Code 171 77
    Beneficiary Country Sweden
    Beneficiary’s Estimated Consumed Amount (EUR) 17,605.42
    VAT Number of Beneficiary SE202100297301
    Beneficiary Group Code LE04
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Public Bodies
    Name of Beneficiary KAROLINSKA INSTITUTET*KAROLINSKA INSTITUTE
    NUTS2 Stockholm
    City SOLNA STOCKHOLM
    Non-Governmental Organisation (NGO) No
  7. Coordinator No
    Address ORIONINTIE 1
    Beneficiary’s Contracted Amount (EUR) 1,632.84
    Beneficiary’s Estimated Contracted Amount (EUR) 1,632.84
    Postal Code 2200
    Beneficiary Country Finland
    Beneficiary’s Estimated Consumed Amount (EUR) 1,632.84
    VAT Number of Beneficiary FI19992126
    Beneficiary Group Code LE05
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Private Companies
    Name of Beneficiary ORION OYJ*ORION CORPORATION
    NUTS2 Helsinki-Uusimaa
    City ESPOO
    Non-Governmental Organisation (NGO) No
  8. Coordinator No
    Address NEW MILLS
    Beneficiary’s Contracted Amount (EUR) 23,445.98
    Beneficiary’s Estimated Contracted Amount (EUR) 23,445.98
    Postal Code GL12 8JR
    Beneficiary Country United Kingdom
    Beneficiary’s Estimated Consumed Amount (EUR) 23,445.98
    VAT Number of Beneficiary GBCZ 422900581
    Beneficiary Group Code LE05
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Private Companies
    Name of Beneficiary RENISHAW PLC
    NUTS2 Gloucestershire, Wiltshire and Bristol/Bath area
    City WOTTON UNDER EDGE
    Non-Governmental Organisation (NGO) No
  9. Coordinator No
    Address .
    Beneficiary’s Contracted Amount (EUR) 23,995.11
    Beneficiary’s Estimated Contracted Amount (EUR) 23,995.11
    Postal Code 291 89
    Beneficiary Country Sweden
    Beneficiary’s Estimated Consumed Amount (EUR) 23,995.11
    VAT Number of Beneficiary SE232100025501
    Beneficiary Group Code LE11
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Member States and national agencies
    Name of Beneficiary SKANE LANS LANDSTING*SKANE LAN
    NUTS2 Sydsverige
    City KRISTIANSTAD
    Non-Governmental Organisation (NGO) No
  10. Coordinator No
    Address HANTVERKARGATAN 45
    Beneficiary’s Contracted Amount (EUR) 32,259.15
    Beneficiary’s Estimated Contracted Amount (EUR) 32,259.15
    Postal Code 10422
    Beneficiary Country Sweden
    Beneficiary’s Estimated Consumed Amount (EUR) 32,259.15
    VAT Number of Beneficiary SE232100001601
    Beneficiary Group Code LE11
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Member States and national agencies
    Name of Beneficiary STOCKHOLMS LANS LANDSTING*STOCKHOLMS LAN*
    NUTS2 Stockholm
    City STOCKHOLM
    Non-Governmental Organisation (NGO) No
  11. Coordinator No
    Address WELLINGTON SQUARE
    Beneficiary’s Contracted Amount (EUR) 19,729.08
    Beneficiary’s Estimated Contracted Amount (EUR) 19,729.08
    Postal Code OX1 2JD
    Beneficiary Country United Kingdom
    Beneficiary’s Estimated Consumed Amount (EUR) 19,729.08
    VAT Number of Beneficiary GB125506730
    Beneficiary Group Code LE04
    Not-for-Profit Organisation (Nfpo) No
    Beneficiary Type Public Bodies
    Name of Beneficiary THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD*UNIVERSITY OF OXFORD
    NUTS2 Berkshire, Buckinghamshire and Oxfordshire
    City OXFORD
    Non-Governmental Organisation (NGO) No

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "Association Europeenne Pour la Maladie de Parkinson - EU funding (€200,000): 732386 - Treater - Clinical Study in Parkinson's Disease with TWO Unique Goals: 1) Proof-of-Concept of Cdnf Protein for Disease Modification; 2) Validation of Clinically Tested Device for Intracerebral Drug Delivery" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.